Meibomian Gland Dysfunction Management With ZEST Protocol

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 10, 2019

Primary Completion Date

March 31, 2020

Study Completion Date

May 31, 2020

Conditions
Meibomian Gland DysfunctionDry Eye SyndromesOcular Surface Disease
Interventions
OTHER

Zocular Eyelid System Treatment

Zocular products contain okra-infused Zocusome micelles that gently lift and clear the oil, debris, and residue on eyelid margins. THerefore, the ZEST treatment is expected to improve signs and symptoms of Meibomian gland dysfunction (MGD) and reduce Contact lens discomfort associated with MGD.

Trial Locations (1)

78229

Rosenberg School of Optometry, San Antonio

All Listed Sponsors
lead

University of the Incarnate Word

OTHER

NCT03968731 - Meibomian Gland Dysfunction Management With ZEST Protocol | Biotech Hunter | Biotech Hunter